CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 4 Grant or award Director acquired 3,990 shares (grant or award)
- 4 Grant or award Director acquired 3,990 shares (grant or award)
- 4 Grant or award Director acquired 3,990 shares (grant or award)
- 4 Grant or award Director acquired 3,990 shares (grant or award)
- 4 Grant or award Director acquired 3,990 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Director gave up 788 shares (to pay taxes)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 90,240 shares at an average $66.62 ($6,012,157)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $67.67 ($5,413,289)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale Chief Executive Officer sold 26,103 shares at an average $69.44 ($1,812,522)
- 144 Insider Sale of Securities
- 4 Planned sale President and CFO sold 13,651 shares at an average $65.08 ($888,419)
- 4 Shares withheld for taxes Chief Executive Officer gave up 36,236 shares (to pay taxes)
Page 3 of 42 · 834 filings